Gefapixant

CHEMBL3716057 Phase 4 معتمد Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

353.4 g/mol

LogP

0.7

Phase

4

This oral medication blocks P2X3 receptors on sensory nerves in the airways to reduce the hypersensitivity that causes chronic, unexplained cough. It is the first medication developed specifically to target this receptor pathway for the treatment of refractory chronic cough.

الوزن الجزيئي

353,4000 g/mol

LogP

0,70

TPSA

165,00 Å²

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Endometriosis Asthma

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1S(N)(=O)=O

InChI

InChI=1S/C14H19N5O4S/c1-7(2)8-4-10(22-3)12(24(17,20)21)5-9(8)23-11-6-18-14(16)19-13(11)15/h4-7H,1-3H3,(H2,17,20,21)(H4,15,16,18,19)

Molecular Formula

C14H19N5O4S

HBD / HBA

3 / 9

الروابط القابلة للدوران

5

الذرات الثقيلة

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This oral medication blocks P2X3 receptors on sensory nerves in the airways to reduce the hypersensitivity that causes chronic, unexplained cough. It is the first medication developed specifically to target this receptor pathway for the treatment of refractory chronic cough.

Yes, Gefapixant is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3716057. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 24764487. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Gefapixant على PillFYI

البنية

بيانات سريعة

الصيغة الجزيئية: C14H19N5O4S

روابط خارجية

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.